Cover Image
Market Research Report
Product code 
1037776

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user(Pharmaceutical, Biotechnology, Academia) - Global Forecast -2026

Published: | MarketsandMarkets | 201 Pages | Delivery time: 1-2 business days

Price

Back to Top
Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user(Pharmaceutical, Biotechnology, Academia) - Global Forecast -2026
Published: November 19, 2021
MarketsandMarkets
Content info: 201 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The global genome editing/genome engineering market is expected to reach USD 11.7 billion by 2026 from USD 5.1 billion in 2021, at a CAGR of 18.2% during the forecast period. The growth of the genome editing/genome engineering market is expected to be driven by the rise in government funding and growth in the number of genomics projects, increased application areas of genomics, and the introduction of CRISPR-Cas9 for genome engineering.

"The services segment accounted for the highest growth rate in the genome editing/genome engineering market, by product & service, during the forecast period"

In 2020, the services segment accounted for the highest growth rate. The genomic editing/genome engineering services market is segmented into sequencing services; data analysis; bioinformatics services; and other services, such as informatics, clean up, gene expression, and DNA synthesis services. Most companies in the services sector offer all these services. Although the services segment represents a major part of the market, some end users have in-house sequencing and bioinformatics capabilities. Service providers possess highly advanced and multiple sequencing platforms and make use of high-quality consumables/kits. They also have multiple sequencing platforms, which enables these service providers to choose the most appropriate system to solve the scientific challenges of their customers and promptly deliver high-quality sequencing at a low cost.

"The CRISPR segment accounted for the largest share of the application segment, by technology, in the genome editing/genome engineering"

In 2020, the CRISPR technology accounted for the largest share. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a revolutionary tool used to edit genes in a way that resembles traditional GMO techniques. The use of the Cas9 enzymes differentiates CRISPR from other forms of genetic modification. The ease of use associated with CRISPR technology gives it a significant advantage over ZFN and TALEN, especially in generating a large set of vectors to target numerous sites or even genome-wide libraries. Another potential advantage of CRISPR is its ability to use multiple guide RNA parallelly to target multiple sites simultaneously in the same cell. This makes it easier to mutate multiple genes at once or engineer precise deletions in a genomic region.

"Asia Pacific: The fastest-growing region in the genome editing/genome engineering market"

The genome editing/genome engineering market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). Increasing government support, and developing R&D infrastructure Increasing investments in research and rising number of applications of gene synthesis for genetic engineering of cells and tissues of organisms are the major factors fueling the growth of the genome editing/genome engineering market in the Asia Pacific region.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70% and Demand Side 30%
  • By Designation: C-level - 55%, D-level - 20%, and Others - 25%
  • By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific (US)
  • Merck KGaA (Germany)
  • GenScript China)
  • Sangamo Therapeutics (US)
  • Lonza (Switzerland)
  • Editas medicine (US)
  • CRISPR Therapeutics
  • Tecan Life sciences (Switzerland)
  • Precision biosciences (US)
  • Agilent technologies (Switzerland)
  • PerkinElmer (US)
  • Cellectis SA (France)
  • Intellia Therapeutics (US)
  • Bluebird Bio (US)
  • Regeneron Pharmaceuticals (US)
  • Synthego (US)
  • Vigene Biosciences (US)
  • Beam Therapeutics (US)
  • Integrated DNA Technologies (US)
  • New England Biolabs (US)
  • Origene Technologies (US)
  • Transposagen Biopharmaceuticals (US)
  • Creative Biogene (US)
  • Recombinetics (US)
  • Caribou Biosciences (US)

Research Coverage:

This report provides a detailed picture of the genome editing/genome engineering market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall genome editing/genome engineering market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.

Table of Contents
Product Code: BT 3380

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES: GENOME EDITING/GENOME ENGINEERING MARKET
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 GENOME EDITING/GENOME ENGINEERING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2020
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2020
    • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 6 GENOME EDITING/GENOME ENGINEERING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
    • FIGURE 7 GENOME EDITING/GENOME ENGINEERING MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
  • 2.4 DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
    • 2.5.1 COVID-19 SPECIFIC ASSUMPTIONS
  • 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 9 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 10 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 GENOME EDITING/GENOME ENGINEERING, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT: GENOME EDITING/GENOME ENGINEERING MARKET

4 PREMIUM INSIGHTS

  • 4.1 GENOME EDITING/GENOME ENGINEERING MARKET OVERVIEW
    • FIGURE 14 GROWING INVESTMENTS IN GENOMICS RESEARCH TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SHARE, BY PRODUCT & SERVICE AND COUNTRY (2020)
    • FIGURE 15 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING/GENOME ENGINEERING MARKET IN NORTH AMERICA IN 2020
  • 4.3 GENOME EDITING/GENOME ENGINEERING SHARE, BY TECHNOLOGY (2020)
    • FIGURE 16 THE CRISPR SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN THE GENOME EDITING/GENOME ENGINEERING MARKET IN 2020
  • 4.4 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 17 THE CELL LINE ENGINEERING SEGMENT EXPECTED TO DOMINATE THE APPLICATIONS MARKET IN 2026
  • 4.5 GENOME EDITING/GENOME ENGINEERING MARKET SHARE, BY END USER, 2020
    • FIGURE 18 THE PHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
  • 4.6 GENOME EDITING/GENOME ENGINEERING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE GENOME EDITING/GENOME ENGINEERING MARKET FROM 2021 TO 2026

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 GENOME EDITING/GENOME ENGINEERING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE
    • TABLE 1 GENOME EDITING/GENOME ENGINEERING MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rise in government funding and growth in the number of genomics projects
      • 5.2.1.2 Increased application areas of genomics
      • 5.2.1.3 Introduction of CRISPR-Cas9
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Off-target effects of CRISPR technology
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Extensive use of genome editing in personalized medicine
      • 5.2.3.2 High growth prospects for the market in emerging countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 High equipment costs
  • 5.3 RANGES/SCENARIOS
    • FIGURE 21 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE GENOME EDITING/GENOME ENGINEERING MARKET
  • 5.4 IMPACT OF COVID-19 OUTBREAK ON THE GENOME EDITING/GENOME ENGINEERING MARKET
    • FIGURE 22 GENOME EDITING/GENOME ENGINEERING SCENARIO WITH AND WITHOUT COVID-19 IMPACT. 2019-2021
  • 5.5 TRENDS/DISRUPTIONS IMPACTING BUSINESSES OF CUSTOMERS
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 23 VALUE CHAIN ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
  • 5.7 TECHNOLOGICAL ANALYSIS
  • 5.8 PATENT ANALYSIS
    • FIGURE 24 PATENT APPLICATIONS FOR GENETIC ENGINEERING MARKET, JANUARY 2011-OCTOBER 2021
    • TABLE 2 INDICATIVE LIST OF PATENTS IN THE GENOME EDITING/GENOME ENGINEERING MARKET
  • 5.9 ECOSYSTEM ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET
    • FIGURE 25 ECOSYSTEM ANALYSIS OF THE GENOME EDITING/GENOME ENGINEERING MARKET
    • TABLE 3 SUPPLY CHAIN ECOSYSTEM
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 GENOME EDITING/ GENOME ENGINEERING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.10.1 THREAT OF NEW ENTRANTS
    • 5.10.2 THREAT OF SUBSTITUTES
    • 5.10.3 BARGAINING POWER OF SUPPLIERS
    • 5.10.4 BARGAINING POWER OF BUYERS
    • 5.10.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
  • 5.11 REGULATORY ANALYSIS
    • 5.11.1 REGULATIONS FOR PRODUCTS DEVELOPED USING GENOME EDITING/GENOME ENGINEERING TECHNOLOGY
      • 5.11.1.1 US
    • TABLE 5 REGULATIONS FOR PRODUCTS DEVELOPED USING GENOME EDITING/GENOME ENGINEERING TECHNIQUES
      • 5.11.1.2 China

6 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 6 GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
  • 6.2 REAGENTS & CONSUMABLES
    • 6.2.1 REAGENTS & CONSUMABLES HOLD THE LARGEST MARKET SHARE
    • TABLE 7 GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 8 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 9 EUROPE: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 10 APAC: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 11 LATAM: GENOME EDITING/GENOME ENGINEERING REAGENTS & CONSUMABLES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 SOFTWARE & SYSTEMS
    • 6.3.1 RISING APPLICATION OF GENOME EDITING/SEQUENCING TO INCREASE THE DEMAND FOR SYSTEMS AND SOFTWARE
    • TABLE 12 GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 13 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 14 EUROPE: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 15 APAC: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 16 LATAM: GENOME EDITING/GENOME ENGINEERING SOFTWARE & SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.4 SERVICES
    • 6.4.1 WIDE APPLICATION OF EDITING/GENOME ENGINEERING SERVICES TO INCREASE MARKET GROWTH
    • TABLE 17 GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 18 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 19 EUROPE: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 20 APAC: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 21 LATAM: GENOME EDITING/GENOME ENGINEERING SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)

7 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 22 GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
  • 7.2 CRISPR
    • 7.2.1 EASE OF USE GIVES CRISPR AN ADVANTAGE OVER OTHER TECHNOLOGIES
    • TABLE 23 GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 24 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 25 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 26 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 27 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR CRISPR, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 TALEN
    • 7.3.1 QUICK MODIFICATIONS IN THE GENOME SEQUENCE ARE POSSIBLE WITH TALEN
    • TABLE 28 GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 29 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 30 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 31 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 32 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR TALEN, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 ZFN
    • 7.4.1 EUKARYOTE CELL STUDIES DONE BY ZFN TO DRIVE MARKET GROWTH
    • TABLE 33 GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 34 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 35 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 36 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 37 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR ZFN, BY REGION, 2019-2026 (USD MILLION)
  • 7.5 ANTISENSE
    • 7.5.1 INCREASED APPLICATION IN ENGINEERING HUMAN CELLS FOR DISEASE STUDY TO DRIVE MARKET GROWTH
    • TABLE 38 GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 39 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 40 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 41 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 42 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR ANTISENSE, BY REGION, 2019-2026 (USD MILLION)
  • 7.6 OTHER TECHNOLOGIES
    • TABLE 43 GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 44 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 45 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 46 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 47 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2019-2026 (USD MILLION)

8 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 48 GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 8.2 CELL LINE ENGINEERING
    • 8.2.1 INCREASING RESEARCH APPLICATIONS OF CELL LINE ENGINEERING TO PROMOTE MARKET GROWTH
    • TABLE 49 GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 50 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 51 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 52 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 53 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR CELL LINE ENGINEERING, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 GENETIC ENGINEERING
    • 8.3.1 ANIMAL GENETIC ENGINEERING
      • 8.3.1.1 Use of animal simulation models in research to increase the demand for genome editing
    • 8.3.2 PLANT GENETIC ENGINEERING
      • 8.3.2.1 Growing attention on GM crops will drive demand for genetic engineering in crops
    • TABLE 54 GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 55 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 56 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 57 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 58 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR GENETIC ENGINEERING, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 DIAGNOSTIC APPLICATIONS
    • 8.4.1 THE GROWING NUMBER OF APPLICATIONS IN DIAGNOSTICS WILL FAVOR MARKET GROWTH
    • TABLE 59 GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 60 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 61 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 62 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 63 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
  • 8.5 DRUG DISCOVERY & DEVELOPMENT
    • 8.5.1 GROWING RESEARCH AND APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET GROWTH
    • TABLE 64 GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 65 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 66 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 67 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 68 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019-2026 (USD MILLION)
  • 8.6 OTHER APPLICATIONS
    • TABLE 69 GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 70 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 71 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 72 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 73 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)

9 GENOME EDITING/ GENOME ENGINEERING MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 74 GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.2 PHARMACEUTICAL COMPANIES
    • 9.2.1 CRISPR TECHNOLOGIES ARE USED BY PHARMACEUTICAL COMPANIES FOR APPLICATIONS IN GENE THERAPIES
    • TABLE 75 GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 76 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 77 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 78 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 79 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2019-2026 (USD MILLION)
  • 9.3 BIOTECHNOLOGY COMPANIES
    • 9.3.1 INCREASING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR MARKET PRODUCTS IN BIOTECH COMPANIES
    • TABLE 80 GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 81 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 82 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 83 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 84 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2026 (USD MILLION)
  • 9.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
    • 9.4.1 TREND OF COLLABORATIVE RESEARCH WILL SUPPORT MARKET GROWTH
    • TABLE 85 GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 86 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 87 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 88 APAC: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 89 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)

10 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 26 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION
    • TABLE 90 GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT
    • TABLE 91 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 92 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 93 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 94 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 95 NORTH AMERICA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 The US dominates the North American market
    • TABLE 96 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 97 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 98 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 99 US: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Availability of research funding in Canada drives the market growth
    • TABLE 100 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 101 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 102 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 103 CANADA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 104 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 105 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 106 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 107 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 108 EUROPE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Strong academic base and rising awareness are key growth drivers in Germany
    • TABLE 109 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 110 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 111 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 112 GERMANY: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 The UK is the largest market for genome engineering in Europe
    • TABLE 113 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 114 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 115 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 116 UK: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Government funding for genomics and rising investments into research show potential for market growth
    • TABLE 117 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 118 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 119 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 120 FRANCE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Increasing collaborations are driving genomic medicine research, thus, boosting the gene editing market in Italy
    • TABLE 121 ITALY: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 122 ITALY: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 123 ITALY: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 124 ITALY: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Proactive research funding by the government to boost the market growth
    • TABLE 125 SPAIN: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 126 SPAIN: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 127 SPAIN: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 128 SPAIN: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 129 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 130 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 131 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 132 ROE: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 28 APAC: GENOME EDITING/GENOME ENGINEERING MARKET SNAPSHOT
    • TABLE 133 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 134 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 135 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 136 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 137 APAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 China to hold the largest share of the market in the Asia Pacific
    • TABLE 138 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 139 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 140 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 141 CHINA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Focus on cancer research showcases favorable scenarios for the market in Japan
    • TABLE 142 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 143 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 144 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 145 JAPAN: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 A growing number of startups and government support indicates growth potential
    • TABLE 146 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 147 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 148 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 149 INDIA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.4 ROAPAC
      • 10.4.4.1 The growth of the market in the RoAPAC is attributed to rising genomic Research
    • TABLE 150 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 151 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 152 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 153 ROAPAC: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • 10.5.1 LATAM
      • 10.5.1.1 The growth of the market in the LATAM is attributed to rising research in genetically modified crops
    • TABLE 154 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 155 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 156 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 157 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 158 LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
      • 10.5.1.2 Brazil
        • 10.5.1.2.1 The rising number of workshops and conferences are increasing awareness, thus, promoting genome editing advancements
    • TABLE 159 BRAZIL: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 160 BRAZIL: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 161 BRAZIL: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 162 BRAZIL: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
      • 10.5.1.3 Rest of LATAM
        • 10.5.1.3.1 Latin America is an attractive market for genomics
    • TABLE 163 REST OF LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 164 REST OF LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 165 REST OF LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 166 REST OF LATAM: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.2 MIDDLE EAST & AFRICA
      • 10.5.2.1 The rising prevalence of genomic disorders in the Middle East and the adoption of genetic testing are driving market growth
    • TABLE 167 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
    • TABLE 168 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 169 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 170 MEA: GENOME EDITING/GENOME ENGINEERING MARKET, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
    • FIGURE 29 KEY PLAYERS STRATEGIES IN THE GENOME EDITING/GENOME ENGINEERING MARKET, 2019- 2021
  • 11.3 MARKET SHARE ANALYSIS
    • FIGURE 30 GENOME EDITING/GENOME ENGINEERING MARKET PLAYER RANKING, 2020
  • 11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 31 TOP MARKET PLAYERS DOMINATED THE GENOME EDITING/GENOME ENGINEERING MARKET IN THE LAST THREE YEARS
  • 11.5 COMPANY EVALUATION QUADRANT
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE
    • 11.5.4 EMERGING COMPANIES
    • FIGURE 32 GENOME EDITING/GENOME ENGINEERING MARKET: COMPANY EVALUATION QUADRANT, 2020
  • 11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 33 GENOME EDITING/GENOME ENGINEERING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
  • 11.7 COMPANY PRODUCT FOOTPRINT
    • TABLE 171 PRODUCT PORTFOLIO ANALYSIS: GENOME EDITING/GENOME ENGINEERING MARKET (2020)
  • 11.8 COMPANY GEOGRAPHIC FOOTPRINT
    • TABLE 172 GEOGRAPHIC REVENUE MIX: GENOME EDITING/GENOME ENGINEERING MARKET (2020)
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 SERVICE/ PRODUCT LAUNCHES
    • 11.9.2 DEALS
    • 11.9.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY COMPANIES
  • (Business overview, Products & Services Offered, Recent developments, MNM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and competitive threats)**
    • 12.1.1 THERMO FISHER SCIENTIFIC
    • TABLE 173 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
    • 12.1.2 MERCK KGAA
    • TABLE 174 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2020)
    • 12.1.3 GENSCRIPT
    • TABLE 175 GENSCRIPT: BUSINESS OVERVIEW
    • FIGURE 36 GENSCRIPT: COMPANY SNAPSHOT (2020)
    • 12.1.4 SANGAMO THERAPEUTICS
    • TABLE 176 SANGAMO THERAPEUTICS: BUSINESS OVERVIEW
    • FIGURE 37 SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2020)
    • 12.1.5 LONZA
    • TABLE 177 LONZA: BUSINESS OVERVIEW
    • FIGURE 38 LONZA: COMPANY SNAPSHOT (2020)
    • 12.1.6 EDITAS MEDICINE
    • TABLE 178 EDITAS MEDICINE: BUSINESS OVERVIEW
    • FIGURE 39 EDITAS MEDICINE: COMPANY SNAPSHOT (2020)
    • 12.1.7 CRISPR THERAPEUTICS AG
    • TABLE 179 CRISPR THERAPEUTICS AG: BUSINESS OVERVIEW
    • FIGURE 40 CRISPR THERAPEUTICS AG: COMPANY SNAPSHOT (2020)
    • 12.1.8 TECAN LIFE SCIENCES
    • TABLE 180 TECAN LIFESCIENCES: BUSINESS OVERVIEW
    • FIGURE 41 TECAN LIFESCIENCES: COMPANY SNAPSHOT (2020)
    • 12.1.9 PRECISION BIOSCIENCES
    • TABLE 181 PRECISION BIOSCIENCES: BUSINESS OVERVIEW
    • FIGURE 42 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2020)
    • 12.1.10 AGILENT TECHNOLOGIES
    • TABLE 182 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW
    • FIGURE 43 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020)
    • 12.1.11 PERKINELMER
    • TABLE 183 PERKINELMER: BUSINESS OVERVIEW
    • FIGURE 44 PERKINELMER: COMPANY SNAPSHOT (2020)
    • 12.1.12 CELLECTIS S.A
    • TABLE 184 CELLECTIS S.A: BUSINESS OVERVIEW
    • FIGURE 45 CELLECTIS S.A: COMPANY SNAPSHOT (2020)
    • 12.1.13 INTELLIA THERAPEUTICS
    • TABLE 185 INTELLIA THERAPEUTICS: BUSINESS OVERVIEW
    • FIGURE 46 INTELLIA THERAPEUTICS: COMPANY SNAPSHOT (2020)
    • 12.1.14 BLUEBIRD BIO INC.
    • TABLE 186 BLUEBIRD BIO: BUSINESS OVERVIEW
    • FIGURE 47 BLUEBIRD BIO: COMPANY SNAPSHOT (2020)
    • 12.1.15 REGENERON PHARMACEUTICALS INC.
    • TABLE 187 REGENERON PHARMACEUTICALS: BUSINESS OVERVIEW
    • FIGURE 48 REGENERON PHARMACEUTICALS: COMPANY SNAPSHOT (2020)
  • 12.2 OTHER PLAYERS
    • 12.2.1 SYNTHEGO CORPORATION
    • 12.2.2 VIGENE BIOSCIENCES
    • 12.2.3 BEAM THERAPEUTICS
    • 12.2.4 INTEGRATED DNA TECHNOLOGIES
    • 12.2.5 NEW ENGLAND BIOLABS
    • 12.2.6 ORIGENE TECHNOLOGIES
    • 12.2.7 TRANSPOSAGEN BIOPHARMACEUTICALS [HERA BIOLABS]
    • 12.2.8 CREATIVE BIOGENE
    • 12.2.9 RECOMBINETICS
    • 12.2.10 CARIBOU BIOSCIENCES
  • *Details on Business overview, Products & Services Offered, Recent developments, MNM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and competitive threats might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS